Jennifer Michaelson, Chief Scientific Officer at Cullinan Therapeutics, Inc. (CGEM), sold 3,143 shares at $11.90 ($38K) on 2025-12-15, disclosed to the SEC on 2025-12-16.
Scheduled sale ($38k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.38 | 2,148 | $27K | 69.2% |
| 2 | $11.90 | 995 | $12K | 30.8% |
| Total | $12.23 avg | 3,143 | $38K | 100% |
| Filing → |
| CGEM | SELL | 2026-07-07 | $143K | — | Filing → |
| CGEM | SELL | 2026-05-06 | $117K | — | Filing → |
| CGEM | SELL | 2026-03-09 | $125K | — | Filing → |